SEC Filing: Form SCHEDULE 13G/A Post date August 14, 2025 Post categories In Uncategorized Filed: 2025-08-14 00:00:00 Filing Summary: Filing Summary Filing Details: SEC Filing Detail Post navigation ←Previous post:Repibresib Phase 2b Vitiligo Topline Results→Next post:VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
VYNE Therapeutics
VYNE Therapeutics